Aster DM special dividend: Rs 118 payout lifts stock

Stock jumps to a fresh 52-week high

Aster DM Healthcare shares rallied more than 14% on Monday to hit a fresh 52-week high, even as the broader market was weak. The move came after the hospital chain operator announced a special dividend of ₹118 per share. The stock opened at ₹550 on the BSE, up 12.7% versus the previous close of ₹487.95. During the session, it rose as much as 14.4% to ₹558.30. At that level, the company’s market capitalisation climbed to ₹26,214 crore. Trading activity also picked up sharply, with 9.5 lakh shares changing hands versus a two-week average of 1.1 lakh.

What the board approved and why it matters

In an exchange filing on Friday, Aster DM said its board approved the special dividend on account of proceeds received from the sale of the GCC business. The dividend is also linked to the redemption of redeemable preference shares issued to the company by Affinity Holdings, a wholly owned material subsidiary. The company said the special dividend will be paid within 30 days from the date of declaration. At the same time, the board decided not to declare an interim dividend for FY2023-24. For shareholders, the announcement clarified how transaction proceeds are being distributed, in line with earlier guidance.

Dividend expectations were already flagged

Aster DM had earlier told investors it intended to consider distributing 70% to 80% of the transaction proceeds as dividends. That guidance indicated a potential payout in the range of ₹110 to ₹120 per share. The announced ₹118 per share sits within that stated range. The market reaction suggests the payout, timing, and visibility on cash receipt were key triggers for the sharp move.

Separation of India and GCC businesses has concluded

Earlier this month, Aster DM said it concluded the separation of its India and GCC businesses, creating two standalone regional healthcare units. Under the plan, a consortium of investors led by Fajr Capital, described as a sovereign-backed private equity firm, acquired a 65% stake in Aster GCC. The Moopen family retained a 35% stake alongside management and operational rights. In the Indian operations, the Moopen family continues to hold a 41.88% stake. The company has positioned this restructuring as a way to create two distinct regional healthcare entities with their own strategic focus.

Transaction proceeds and cash consideration details

Following the conclusion of the transaction, Affinity Holdings Limited, a wholly owned subsidiary of the company, received a cash consideration of $107.6 million. In an earlier update on the proposed sale, Aster DM had said it would receive $1.001 billion, with $103 million payable at closing. It also indicated about $18.8 million may be received subsequently, subject to contingent events, including an earnout of up to $10 million based on EBITDA achieved by the GCC business for FY24. These figures framed the scale of the transaction and helped investors assess how much of the proceeds could be available for shareholder returns.

Timeline: approvals, shareholder vote, and market moves

The separation plan was approved by Aster DM’s board in November 2023 and later approved by shareholders in January 2024. A PTI report said shareholders approved the proposal to hive off the Gulf business in a deal valued at $1.01 billion, with over 99% of votes polled in favour. After the segregation announcement and subsequent updates, the stock saw multiple sharp moves across trading sessions. The company’s filings also noted the transaction was subject to customary regulatory approvals, contractual approvals, and closing conditions, which were satisfied as the deal concluded.

How the stock has performed around the announcements

Aster DM’s stock has surged 37% since April 3, after the company informed exchanges that it completed the separation of its India and GCC verticals. At Monday’s high, the share price was up 133% compared with its 52-week low of ₹238.90 on May 8, 2023. The counter has registered gains of 110% over 12 months, 56% in six months, and 29% in calendar year 2024. Over the last month, it has added 21%, and it climbed nearly 8% in a week. These moves show that the separation and capital return narrative has been central to recent price action.

Key facts at a glance

India strategy after the split: capacity expansion plan

Post segregation, Aster DM Healthcare in India has said it plans to focus on geographic growth through greenfield and brownfield expansions over the next three years. The company has indicated a plan to add 1,700 beds by FY27 through the organic route. It also said it will look for expansion through the inorganic route. These targets provide a roadmap for capital deployment and growth, separate from the Gulf business, which is now under a different ownership structure.

Market impact and what investors tracked

The immediate market impact was concentrated in three areas: confirmation of cash receipt, clarity on the dividend amount, and evidence that the separation process had moved from announcement to completion. The spike in volumes relative to the two-week average suggested broader participation in the move, not only marginal buying. The company’s decision not to declare an interim dividend for FY2023-24 also signalled that the special dividend is the primary near-term cash return event tied to the transaction. Separately, broker commentary cited in the provided reports included a Prabhudas Lilladher “buy” recommendation with a target price of ₹515, reflecting how sell-side views were also part of the trading backdrop.

Conclusion

Aster DM Healthcare’s ₹118-per-share special dividend, tied to proceeds from the GCC business sale and related redemptions, pushed the stock to a fresh 52-week high amid heavy volumes. With the India-GCC separation concluded and the ownership structure clarified, investor focus is likely to remain on dividend timelines and the company’s stated India expansion plans, including the FY27 bed-addition target.